Couldn’t agree more wombat. One thing is now virtually a certain, the Board will not be able to raise anymore funds after these last 2 CR’s. In a weird way I hope Oncosil just disappears. I won’t be shedding a tear. This has been a very costly exercise.
Why should shareholders continue to underwrite a failed business model? The answer is the market will eventually say no more. Lights out!
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-135
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.0¢ | $120.4K | 10.96M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 448751 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 5051473 | 8 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |